Chapel Hill CRS (Site ID: 3201)

Chapel Hill, North Carolina 27599

0 studies enrolling now · 3 studies all time

What they study most

Aging Problems, Covid19, Frailty, HIV, HIV Infection, Prefrail, SARS-CoV2 Infection

Studies at this site

• Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption — Running, not enrolling
• Improving Physical Ability and Cellular Senescence Elimination in HIV — Running, not enrolling
• SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine — Completed